Efficacy and Tolerability of First-Line Anti-eGFR and Anti-VEGF Therapy in Elderly Patients with Ras-Wild Metastatic Colon Cancer

Introduction: Adding targeted agents to chemotherapy for metastatic colorectal cancer increases survival. There have been no clinical trials in older populations comparing the efficacy of the targeted agents. We aimed to compare the efficacy and tolerability of anti-epidermal growth factor receptor...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Ender Doğan, Sedat Tarık Fırat, Murat Eser, Oktay Bozkurt, Mevlüde İnanç, Metin Özkan
Formato:	Artigo
Idioma:	Inglês
Publicado em:	İstanbul Training and Research Hospital 2024-08-01
Colecção:	İstanbul Medical Journal
Assuntos:	colon cancer vascular endotelial growth factor epidermal growth factor elderly
Acesso em linha:	https://istanbulmedicaljournal.org/articles/efficacy-and-tolerability-of-first-line-anti-egfr-and-anti-vegf-therapy-in-elderly-patients-with-ras-wild-metastatic-colon-cancer/doi/imj.galenos.2024.78278
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!